Related Experiment Videos
Adenoidectomy for otitis media with effusion
1Virginia Merrill Bloedel Hearing Research Center, Department of Otolaryngology-Head and Neck Surgery, University of Washington, Seattle 98195.
Abstract:
The efficacy of adenoidectomy in the surgical treatment of children with otitis media with effusion (OME) persisting after adequate medical therapy has been established in three independent randomized clinical trials. Although each of these studies used a different experimental design, all showed significant reductions in morbidity from OME after adenoidectomy as compared to the control groups. Subsequent application of these findings in formulating clinical guidelines for the use of adenoidectomy has yet to be realized, and recommendations to parents for or against the procedure appear to vary more with the surgeon's philosophy than with the condition of the child. This discussion examines the effectiveness and cost of adenoidectomy for the treatment of children with chronic OME and addresses the question of whether adenoidectomy should be used as a primary or a secondary surgical therapy. The argument is made to use adenoidectomy as a primary therapy in selected cases on the basis of patient age, type of OME, and patient preference, and to base the decision not on the size of the adenoid, but on its known pathophysiology.
Insights
Adenoidectomy effectively treats children with persistent otitis media with effusion (OME) after medical therapy, reducing illness. Clinical guidelines should reflect this evidence, guiding surgeons to offer adenoidectomy as a primary option for selected pediatric patients.
Area of Science:
- Otolaryngology
- Pediatric Surgery
- Evidence-Based Medicine
Background:
- Otitis media with effusion (OME) is a common pediatric condition.
- OME can persist despite medical management, impacting children's health.
- Previous randomized trials established adenoidectomy's efficacy for OME.
Purpose of the Study:
- To review the effectiveness and cost of adenoidectomy for chronic OME in children.
- To evaluate adenoidectomy as a primary versus secondary surgical therapy.
- To advocate for evidence-based guidelines in OME treatment decisions.
Main Methods:
- Analysis of three independent randomized clinical trials on adenoidectomy for OME.
- Examination of clinical guidelines and current surgical practice variations.
- Discussion of cost-effectiveness and patient-centered decision-making factors.
Main Results:
- All three trials demonstrated significant OME morbidity reduction with adenoidectomy compared to controls.
- Clinical guidelines have not fully incorporated these findings.
- Surgeons' recommendations often vary based on philosophy rather than objective criteria.
Conclusions:
- Adenoidectomy is an effective treatment for children with persistent OME.
- It should be considered a primary surgical therapy in select cases.
- Treatment decisions should prioritize patient age, OME type, and preference, not solely adenoid size.